Last reviewed · How we verify

NCT03611062

VR-based EF Rehabilitation for Pediatric TBI

Completed NA Results posted Last updated 14 September 2021
What this trial tests

NA trial testing VR Executive Functions Training in Traumatic Brain Injury in 27 participants. Completed in 12 August 2020.

Timeline
15 August 2018
Primary endpoint
12 August 2020
12 August 2020

Quick facts

Lead sponsorUniversity of Massachusetts, Lowell
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeother
Enrollment27
Start date15 August 2018
Primary completion12 August 2020
Estimated completion12 August 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Massachusetts, Lowell

Who can join

Adults 7 to 17, any sex, with Traumatic Brain Injury. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Level of Simulator Sickness [Feasibility and Safety] Primary · Post-Intervention, up to 30 minutes after intervention

Measured by the Simulator Sickness Questionnaire. Total scores range from 0 to 26, with 0 representing a better outcome of less sickness.

GroupValue95% CI
VR Executive Functions Training0.16± 0.19
Control0.03± 0.04
Level of Physical Fatigability [Feasibility and Safety] Primary · Post-Intervention, up to 30 minutes after intervention

Measured by the Borg Rating of Perceived Exertion Scale. Total score ranges from 6 to 20, with 6 being a lower amount of exertion.

GroupValue95% CI
VR Executive Functions Training6.25± 0.50
Control11.50± 2.12
Perceived Virtual Reality Experience [Feasibility] Primary · Post-Intervention, up to 30 minutes after intervention

Measured by asking participants to respond to the following question: How much did you like the VR games you just played? Measured on a scale 1-5, with higher values indicating greater enjoyment

GroupValue95% CI
VR Executive Functions Training3.75± 0.96
Control4± 0

Adverse events — posted to ClinicalTrials.gov

Time frame: During the course of the study participation (up to 30 minutes after study completion). Reporting threshold: 0%. Adverse-event reports describe events observed during the trial — not all are caused by the drug.

VR Executive Functions Training
Serious: 0/13 (0%)
Deaths: 0/13
Control
Serious: 0/12 (0%)
Deaths: 0/12
Other adverse events (2 terms — click to expand)

ReactionSystemVR Executive Functions Tra…Control
Blurry vision / eye strainEye disorders
HeadacheGeneral disorders

Data from ClinicalTrials.gov NCT03611062 adverse events section.

Sponsor's own description

Childhood traumatic brain injury (TBI) poses significant impairment in children's executive functions (EFs) for moderate to severe injuries, yet interventions specifically designed for children's EF rehabilitation post-TBI and rigorous clinical trials to establish the safety and efficacy of such interventions remain unavailable. In this study, the investigators will conduct a small-scale pilot randomized clinical trial to evaluate the safety and preliminary efficacy of a novel virtual reality (VR)-based training program for EF rehabilitation for mild complicated to severe childhood TBI. Knowledge from this research will provide empirical evidence for a larger-scale RCT after the conclusion of this pilot study, with the aim to improve the long-term health and quality of life in children with TBI, as well as promote efficiency and effectiveness of future psychological rehabilitation for children with TBI.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. VR-based cognitive rehabilitation for children with traumatic brain injuries: Feasibility and safety.
    Shen J, Lundine JP, Koterba C, Udaipuria S, et al · · 2022 · cited 8× · PMID 35862105 · DOI 10.1037/rep0000458

Verify or expand the search:

Other recruiting trials for Traumatic Brain Injury

Currently open trials in the same condition.

Other University of Massachusetts, Lowell trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03611062.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing